During the past decade, Hematology-Oncology Associates of Rockland conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology-Oncology Associates of Rockland" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematology-Oncology Associates of Rockland" are "Ovarian Neoplasms" (2 trials), "Adenocarcinoma" (1 trials), "Gastric Cancer" (1 trials), "Neoplasm Metastasis" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Hematology-Oncology Associates of Rockland" in a lesser frequency.

Most popular intervention types in "Hematology-Oncology Associates of Rockland" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "5-FU/cisplatin" (1 trials), "Dasatinib" (1 trials), "Doxorubicin HCl Liposome Injection" (1 trials), "S-1/Cisplatin" (1 trials) and "TLK286 HCl for injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology-Oncology Associates of Rockland" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hematology-Oncology Associates of Rockland". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hematology-Oncology Associates of Rockland, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology-Oncology Associates of Rockland, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".